Boothbay Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Boothbay Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,100	Closed	-$505K	–	2017
2022 Q3	$505K	Buy	7,100 +4,100	+137%	+$297K	0.01%	1226
2022 Q2	$231K	Sell	3,000 -7,000	-70%	-$533K	0.01%	1637
2022 Q1	$730K	Sell	10,000 -6,500	-39%	-$436K	0.02%	1093
2021 Q4	$1.03M	Buy	+16,500	New	+$968K	0.02%	734
2020 Q4	–	Sell	-337	Closed	-$2.03M	–	1238
2020 Q3	$2.03M	Buy	+337	New	+$20.3K	0.12%	223
2019 Q2	–	Sell	-3,025	Closed	-$14.4M	–	750
2019 Q1	$14.4M	Buy	3,025 +2,577	+575%	+$128K	1.4%	7
2018 Q4	$2.33M	Hold	448	–	–	0.34%	57
2018 Q3	$2.78M	Hold	448	–	–	0.27%	79
2018 Q2	$2.48M	Sell	448 -404	-47%	-$21.8K	0.22%	85
2018 Q1	$5.39M	Buy	+852	New	+$54.8K	0.64%	33

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's BMY Position: Q1 2026 in Review

Boothbay Fund Management increased its Bristol-Myers Squibb (BMY) stake by 667% in Q1 2026, buying an estimated $2.77M and bringing the position to 54,567 shares worth $3.31M. The position accounts for 0.04% of the portfolio, ranked #437.

Boothbay Fund Management first reported a position in BMY in Q1 2016 and has held it in 25 quarters since. The position peaked at $5.13M in Q1 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Boothbay Fund Management held 54,567 shares of Bristol-Myers Squibb worth $3.31M as of Q1 2026.
Boothbay Fund Management bought 47,450 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.77M.
Bristol-Myers Squibb made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #437 holding.
Boothbay Fund Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 25 quarters since.
Boothbay Fund Management's Bristol-Myers Squibb position peaked at $5.13M in Q1 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.